Article

The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer

2024-03-22

Abstract excerpt

<title>Abstract</title> <p>SLAMF9 is a member of the family of conserved lymphocyte activation molecules (SLAMF), Unlike other SLAMs, which have been extensively studied, investigations on SLAMF9 have primarily concentrated on an individual or limited number of types of cancers, but without systematic investigation across different cancer types. Through systematic pan-cancer analysis, we demonstrated that SLAMF9...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e0ea4a9-1b8f-541e-bd53-9d1987da0385
DOI: 10.21203/rs.3.rs-3996918/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancerDOI 10.21203/rs.3.rs-3996918/v1Read

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancerSemantic proximity Read

SLAMF8, a potential novel immune checkpoint molecule, is associated with the prognosis of colorectal cancerSemantic proximity Read

SLAMF6 appears bidirectional in immune regulation of different cancersSemantic proximity Read

LIMK1: A Promising Prognostic and Immune Infiltration Indicator in Colorectal CancerSemantic proximity Read

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read

TNMD in pan-cancer analysis: Exploring its impact on immune modulation and uncovering functional insights in colorectal cancerSemantic proximity Read

Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal CancerSemantic proximity Read

MEIS3 Drives Malignant Progression and Contributes to an Immunosuppressive Microenvironment in Stomach AdenocarcinomaSemantic proximity Read

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read

SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinomaSemantic proximity Read

The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.Semantic proximity Read

CD9, a tetraspanin target for cancer therapy?Semantic proximity Read